Universal access - But when? Treating the right patient at the right time: Access to electrophysiology services in Canada

Canadian Journal of Cardiology

Volumn 22, Issue 9, 2006, Pages 741-746

  Simpson, Christopher S ^a,k   Healey, Jeffrey S ^b   Philippon, Francois ^c   Dorian, Paul ^d   Mitchell, L Brent ^e   Sapp Jr , John L ^f   O'Neill, Blair J ^f   Sholdice, Marcella M ^g   Green, Martin S ^h   Sterns, Larry D ⁱ   Yee, Raymond ^j  

^a QUEEN S UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

^f DALHOUSIE UNIVERSITY   (Canada)

^g Canadian Cardiovascular Society   (Canada)

^h UNIVERSITY OF OTTAWA   (Canada)

ⁱ ROYAL JUBILEE HOSPITAL   (Canada)

^j UNIVERSITY OF WESTERN ONTARIO   (Canada)

^k KINGSTON GENERAL HOSPITAL   (Canada)

more..

Author keywords

Access ot care; Arrhythmias; Electrophysiology; Health policy

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CANADA; CARDIAC RESYNCHRONIZATION THERAPY; CATHETER ABLATION; CONSENSUS DEVELOPMENT; CONSULTATION; DEFIBRILLATION; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; EVIDENCE BASED MEDICINE; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MEDICAL DECISION MAKING; MEDICAL EXPERT; MEDICAL SOCIETY; MEDICAL SPECIALIST; MORTALITY; PATIENT CARE; PATIENT REFERRAL; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; TIME; TREATMENT PLANNING;

EID: 33747192895     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(06)70289-6     Document Type: Article

References (30)

1. Simpson CS, Hoffmaster B, Dorian P. Downward delegation of implantable cardioverter defibrillator decision-making in a restricted-resource environment: The pitfalls of bedside rationing. Can J Cardiol 2005;21:595-9.
2. Cleland JG, Daubert JC, Erdmann E, et al; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.
3. Stabile G, Bertaglia E, Senatore G, et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: A prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J 2006;27:216-21.
4. Naylor CD, Levinton CM, Wheeler S, Hunter L. Queueing for coronary surgery during severe supply-demand mismatch in a Canadian referral centre: A case study of implicit rationing. Soc Sci Med 1993;37:61-7.
5. Hippisley-Cox J, Pringle M. Inequalities in access to coronary angiography and revascularisation: The association of deprivation and location of primary care services. Br J Gen Pract 2000;50:449-54.
6. Carroll RJ, Horn SD, Soderfeldt B, James BC, Malmberg L. International comparison of waiting times for selected cardiovascular procedures. J Am Coll Cardiol 1995;25:557-63.
7. Massel D. Access to an outpatient cardiology consultation in southwestern Ontario. Can J Cardiol 1999;15:879-83.
8. Naylor CD, Levinton CM, Baigrie RS. Adapting to waiting lists for coronary revascularization. Do Canadian specialists agree on which patients come first? Chest 1992;101:715-22.
9. Vora AM, Green MS, Tang AS. Safety and feasibility of same day discharge in patients undergoing radiofrequency catheter ablation. Am J Cardiol 1998;81:233-5.
10. Bathina MN, Mickelsen S, Brooks C, Jaramillo J, Hepton T, Kusumoto FM. Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs. Am J Cardiol 1998;82:589-93.
11. Marshall DA, O'Brien BJ, Nichol G. Review of economic evaluations of radiofrequency catheter ablation for cardiac arrhythmias. Can J Cardiol 2003;19:1285-304.
12. Sintetos AL, Roark SF, Smith MS, McCarthy EA, Lee KL, Pritchett EL. Incidence of symptomatic tachycardia in untreated patients with paroxysmal supraventricular tachycardia. Arch Intern Med 1986;146:2205-9.
13. Yee R, Connolly S, Noorani H. Clinical review of radiofrequency catheter ablation for cardiac arrhythmias. Can J Cardiol 2003;19:1273-84.
14. La Gestion De L'acces Aux Services En Cardiologie Tertiare. In: College des medecins du quebec et Reseau Quebecois de cardioloie tertiaire, November 2003.
15. Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 1979;301:1080-5.
16. Mittal S, Iwai S, Stein KM, Markowitz SM, Slotwiner DJ, Lerman BB. Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. J Am Coll Cardiol 1999;34:1082-9.
17. Goldman BS, Nishimura S, Lau C. Survey of Cardiac Pacing in Canada (1993). Can J Cardiol 1996;12:573-8.
18. Crysler Report on the Canadian Cardiovascular Market, 2005.
19. Simpson CS, Fisher MA, Curtis MJ, et al. Correlation of waiting time with adverse events in patients admitted for nonelective permanent pacemaker implantation. Can J Cardiol 1998;14:817-21.
20. Leung WM, Simpson CS, Abdollah H, Ropchan GV, Brennan FJ. Effect of a dedicated implant facility on waiting times and morbidity in patients requiring pacemakers. Pacing Clin Electrophysiol 2003;26:S145.
21. Molin F, Page P, Daoust L. Implantation of permanent pacemakers in the electrophysiology laboratory: What it has changed in a general teaching hospital. Can J Cardiol 2000;16:871-5.
22. Simpson CS, O'Neill BJ, Sholdice MM, et al. Canadian Cardiovascular Society commentary on implantable cardioverter defibrillators in Canada: Waiting times and access to care issues. Can J Cardiol 2005;21(Suppl A):19A-24A.
23. Moss AJ, Zareba W, Hall WJ, et al; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
24. Tang AS, Ross H, Simpson CS, et al. Canadian Cardiovascular Society/ Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada. Can J Cardiol 2005;21(Suppl A):11A-18A.
25. Arnold JM, Liu P, Demers C, et al; Canadian Cardiovascular Society. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management. Can J Cardiol 2006;22:23-45.
26. Krum H. The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: Full text (update 2005). Eur Heart J 2005;26:2472.
27. Al-Khatib SM, Sanders GD, Mark DB, et al. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: Randomized trial evidence through 2004. Am Heart J 2005;149:1020-34.
28. Ellenbogen KA, Wood MA, Klein HU. Why should we care about CARE-HF? J Am Coll Cardiol 2005;46:2199-203.
29. Bristow MR, Saxon LA, Boehmer J, et al; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
30. Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure: A meta-analysis of randomized controlled trials. JAMA 2003;289:730-40.